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Manipulation of gene expression on a genome-wide level is one of the most important
systematic tools in the post-genome era. Such manipulations have largely been enabled
by expression cloning approaches using sequence-veriﬁed cDNA libraries, large-scale
RNA interference libraries (shRNA or siRNA) and zinc ﬁnger nuclease technologies. More
recently, the CRISPR (clustered regularly interspaced short palindromic repeats) and
CRISPR-associated (Cas)9-mediated gene editing technology has been described that holds
great promise for future use of this technology in genomic manipulation. It was suggested
that the CRISPR system has the potential to be used in high-throughput, large-scale loss of
function screening. Here we discuss some of the challenges in engineering of CRISPR/Cas
genomic libraries and some of the aspects that need to be addressed in order to use this
technology on a high-throughput scale.
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BACKGROUND
Advances in lab automation and completion of the human genome
project have resulted in the design of large-scale whole-genome
libraries encompassing thousands of samples in a single run.
These developments build on technological advances made by
the pharmaceutical industry that required a need for screening
large collections of chemical compounds in a very cost-effective
manner and were subsequently adopted by academic institu-
tions for chemical compound screening as well as expression
cloning applications. Such large-scale screening approaches have
enabled the unbiased identiﬁcation of cell-based phenotypes
and led to several ground-breaking discoveries, in particular
for the identiﬁcation of cell surface and virus receptors (Seed,
1995).
Expression cloning relies on the generation of an expressed
cDNA library that can be transfected into target cells for assess-
ment of changes in a cellular reporter activity or phenotype.
Over the years, a complementary approach was developed based
on the use of “antisense” constructs without a proper under-
standing of the underlying mechanisms. Eventually, after the
discovery of RNA interference in the late 1990s and the devel-
opment of mammalian siRNA libraries in the early 2000s,
such knockdown technologies became mainstream for interro-
gating gene defects on a genome-wide scale. To date, siRNA
genome-wide libraries are still the main application in genomic
high-throughput screening, partially because of the lack of alter-
native methods. In recent years, many key problems of RNAi
technology have become apparent, such as off-target effects, vari-
able levels of knockdown efﬁciency and low-level conﬁdence
in hits of screening campaigns (Buehler et al., 2012; Marine
et al., 2012). Hence, the siRNA screening community is openly
discussing the need for alternative systems to overcome these
limitations.
An alternative way of modifying the mammalian genome on
a large-scale may lie in the use of genome editing technologies
such as the use of targeted endonucleases. While zinc ﬁnger
nucleases (ZFNs) and transcription activator-like effector nuclease
(TALEN)s are highly useful for gene editing, the cost and time
to engineer the system makes it incompatible for the genera-
tion of large-scale whole-genome libraries. In particular, ZFN or
TALENs require engineering of a protein component for each
gene locus and this may not be amenable or cost-effective on
a large-scale. With the CRISPR (clustered regularly interspaced
short palindromic repeats)/Cas9 system, a cost-effective method
that combines targeted genome editing with a simple, less time-
consuming assay set-up is emerging and may be compatible with
high-throughput screening approaches. An overview of the main
techniques for genome editing and gene silencing is given in
Table 1 and a detailed assessment of the advantages and disad-
vantages of genome editing methods has been given elsewhere
(Ramalingam et al., 2013).
CRISPR/Cas9
The CRISPR/Cas9 system, originally exploited from Streptococcus
pyogenes, is a general bacterial host defense mechanism to detect
and degrade exogenous sequences from invading bacteriophages
(Sorek et al., 2013). Short segments of foreign DNA are processed
by CRISPR-associated (Cas) proteins into small elements which
are then inserted into the CRISPR locus. RNAs from the CRISPR
loci are constitutively transcribed and processed into small RNAs
(crRNA) of exogenously derived DNA. These small RNAs then
guide other Cas proteins such as Cas9 tomediate sequence-speciﬁc
degradation of the foreign DNA. As such, the system serves two
critical functions of acquired immunity, memory and pathogen
elimination, and has some resemblance with acquired immunity
in higher organisms. This system relies on the DNA endonuclease
Cas9 that is targeted to a speciﬁc region of the genome to direct
cleavage of the DNA in a sequence-speciﬁc manner (Jinek et al.,
2012). Binding of Cas9 to the DNA is mediated by a partially com-
plementary trans-acting RNA (tracrRNA) and cleavage is directed
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Table 1 | Overview of genome editing and gene silencing technologies.
Name Components Mechanism of action Specificity/off-target
effects
Possibility to rapidly
generate large-scale
libraries
Genome editing
Zinc ﬁnger nucleases
(ZFNs)
Fok1 restriction nuclease fused to
multiple zinc ﬁnger peptides; each
targeting 3 bp of genomic
sequence
Induces double-strand breaks in
target DNA
Can have off-target
effects
No – requires
customization of protein
component for each
gene
Transcription
activator-like effector
nucleases (TALENs)
Non-speciﬁc DNA-cleaving
nuclease fused to a DNA-binding
domain speciﬁc for a genomic
locus
Induces double-strand breaks in
target DNA
Highly speciﬁc Feasible, but technically
challenging (Reyon et al.,
2012)
Homing
meganucleases
Endonuclease with a large
recognition site for DNA
(12–40 base pairs)
Induces double-strand breaks in
target DNA
Highly speciﬁc No – limited target
sequence speciﬁcity
available
CRISPR/Cas 20 nt crRNA fused to tracrRNA
and Cas9 endonuclease
Induces double-strand breaks in
target DNA (wt Cas9) or
single-strand DNA nicks (Cas9
nickase)
Some off-target effects
that can be minimized by
selection of unique
crRNA sequences
Yes – requires simple
adapter cloning of 20 nt
Oligos targeting each
gene into a plasmid
Gene silencing
Post-transcriptional
gene silencing (e.g.,
RNA interference)
Double-stranded RNA DICER-mediated mRNA
degradation;
(post-transcriptional)
Can have signiﬁcant
off-target effects
Yes (Moffat et al., 2006)
Morpholino
oligonucleotides
Synthetic oligonucleotide analogs Sterical blocking of translation
initiation complex;
(post-transcriptional)
Can have signiﬁcant
off-target effects
Feasible, but technically
challenging
CRISPRi sgRNA and catalytically inactive
Cas9
Transcriptional repression of
RNA synthesis
To be determined Yes
by a mature CRISPR RNA (crRNA; Deltcheva et al., 2011; Jinek
et al., 2012). These three components, the Cas endonuclease, the
tracrRNA, and crRNA are the basic constituents of this genome
editing system.
By modifying these basic constituents for the use in other
organisms, the CRISPR/Cas9 system has been shown to be a use-
ful tool for gene editing and silencing. CRISPR sequences can
be engineered which give rise to crRNA directed against speciﬁc
endogenous genes in various organisms. Signiﬁcant advances for
the use of this technique have been promoted by the generation
of a “single-guide RNA” (sgRNA) that combines the function of
the tracrRNA and crRNA in a chimeric molecule (Jinek et al.,
2012, 2013). By now the CRISPR/Cas9 system has been success-
fully used to target genomic loci in mammalian cell lines (Cho
et al., 2013; Cong et al., 2013; Mali et al., 2013; Wang et al., 2013),
zebraﬁsh (Chang et al., 2013; Hwang et al., 2013), fungi (Dicarlo
et al., 2013), bacteria (Jiang et al., 2013; Mali et al., 2013), C. ele-
gans (Friedland et al., 2013),Drosophila (Gratz et al., 2013), plants
(Li et al., 2013b; Nekrasov et al., 2013; Shan et al., 2013), rats
(Li et al., 2013a,c), and mice (Wang et al., 2013). For instance,
gene knockout mice can be rapidly generated when the desired
gene locus is targeted via CRISPR/Cas9 (Wang et al., 2013). Quite
importantly, multiple loci can be targeted at the same time by
incorporation of multiple crRNA sequences (Cho et al., 2013;
Wang et al., 2013). In zebraﬁsh, where RNAi-based methods have
limited capability, the use of CRISPR has enabled the genera-
tion of whole animals deﬁcient in multiple gene loci (Chang
et al., 2013; Hwang et al., 2013). The same system has been used
to site-speciﬁcally insert mloxP sites, making it a novel reverse
genetic tool for genome modiﬁcation (Chang et al., 2013). In
zebraﬁsh and Drosophila it has been shown that CRISPR/Cas9
genome editing is inheritable with germline transmission reach-
ing nearly 100% (Basset et al., 2013; Hwang et al., 2013;
Yu et al., 2013).
Up to date three different versions of the Cas9 component have
been described for the use in mammalian cells.
(A) Wild-type humanized (h)Cas9: Wild-type Cas9 will intro-
duce a double-strand break (DSB) at the region it is targeted
to, thus resulting in activation of the DSB repair machinery.
Consequently, this will lead to insertion or deletion of nucleotides
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at the site of injury of the DSB and lead to alterations in the DNA
sequence and ultimately in gene expression.
(B) hCas9 D10A nickase: The wild-type endonuclease activ-
ity of Cas9 may, however, result in genome rearrangements
that can lead to deleterious effects, e.g., selection against cells
expressing wild-type Cas9 was observed (Qi et al., 2013). Fur-
thermore, the generation of insertion/deletions (indels) at the
target region as a consequence of DSB repair may lead to
unwanted side-effects (Ketteler, 2012). To avoid those effects,
Cong et al. used a mutant Cas9 nickase that only generates
a nick in the genomic DNA at the target region, which in
turn is repaired through high-ﬁdelity homology-directed repair,
rather than the error-prone Cas9 endonuclease-mediated non-
homologous end-joining repair (Cong et al., 2013). The exper-
iments to date suggest that this mutant Cas9 nickase shows
similar targeting efﬁciencies compared to wild-type Cas9. Another
advantage of the nickase system is that it can be used for gen-
erating knockout as well as knockin genotypes. This can be
achieved by co-transfection of a recombination cassette with 5′-
and 3′-ﬂanking homology regions. However, knockout/knockin
constructs based on the Cas9 nickase system require engi-
neering of homologous recombination cassettes for each gene
locus, thus making it technically challenging to implement on
a large-scale.
(C) Catalytically dead dCas9: Qi et al. (2013) took a step
further to generate a catalytically dead Cas9 lacking endonu-
clease activity. This resulted in gene silencing rather than gene
editing of the target locus. This offers a signiﬁcant advan-
tage over classic RNAi-based silencing since mRNA synthesis
is altered at an early stage of transcription by blocking RNA
polymerase and transcript elongation whereas in RNA interfer-
ence, the expressed synthesized mRNA is degraded. With this
novel system, termed CRISPRi, the promoter region can also
be targeted to efﬁciently knock down expression of the tran-
script. Moreover, Qi et al. (2013) showed that CRISPRi can
be used to simultaneously repress multiple target genes (simi-
lar to chimeric hairpin constructs in RNAi, Gil-Humanes et al.,
2010), which opens new strategies for large-scale proﬁling of
genetic interactions in mammalian cells. The CRISPRi has enor-
mous potential for gene silencing applications. Recently, it was
shown that catalytic dead Cas9 can be fused to a general repres-
sor or activator protein such as KRAB or VP16, respectively,
and thereby result in highly efﬁcient gene silencing or activa-
tion (Gilbert et al., 2013). Furthermore, an inducible silencing
system has been described, thus expanding the versatility of this
approach. It is conceivable that catalytic dead Cas9 and the
associated sgRNA serves as genomic targeting tools, allowing
genomic site-speciﬁc modiﬁcations. The versatility of this sys-
tem is very attractive, allowing modiﬁcations that reach beyond
the scope of RNAi libraries. Further studies are required to
address whether silencing efﬁciency is similar to RNAi-mediated
silencing.
Overall, the three described Cas9 systems show advantages
dependingon the application. For instance,wild-typehCas9 seems
best suited to generate gene knockouts, nickase hCas9 D10A for
gene replacement strategies and catalytically dead dCas9 for gene
silencing.
HIGH-THROUGHPUT SCREENING USING CRISPR/Cas9
Recent improvements have enabled the use of the CRISPR/Cas9
system as a novel tool to manipulate speciﬁc genomic regions.
These developments have prompted the proposal to use this
technology to set-up high-throughput screening approaches anal-
ogous to siRNA-mediated large-scale screening experiments (Qi
et al., 2013). Next,wewould like to consider some aspects that need
to be addressed to enable the generation of large-scale CRISPR
(crRNA) libraries.
(1) Design
(2) Coverage
(3) Efﬁciency of knockdown
(4) Off-target effects
(5) Delivery
DESIGN
Several possible conﬁgurations of the CRISPR/Cas9 system exist
(see Figure 1). The most striking advantage for all of them is the
simplicity by which a gene can be targeted. Twomain components
are required: ﬁrst, a codon-optimized version of Cas9 endonu-
clease and second, the RNA components crRNA and tracrRNA.
The DNA sequence encoding the crRNA has a length of about 20
nucleotides and is also known as protospacer. At the 3′ end the
crRNA sequence must ﬁnish with a 2 bp (base pair) protospacer
adjacent motif (PAM) of the sequence GG or AG. The crRNA
sequence can be designed as complementary to the + or − strand
of the target DNA region. As mentioned before it is possible to
combine the crRNA sequence with the tracrRNA sequence in a
sgRNA. Also CRISPR vectors for the expression of sgRNA and
Cas9 from a single plasmid can be obtained from various sources
via Addgene1. The generation of a genomic library for genome
editing (using wild-type Cas9 or Cas9 nickase) or gene silencing
(using catalytic inactive Cas9) can be achieved by a simple cloning
of short DNA oligonucleotides into the respective CRISPR vec-
tors. Protocols for plasmid construction and sub-cloning are freely
available2,3. Protocols for automation of such cloning on a large-
scale have previously been developed and applied to the generation
of genome-wide shRNA libraries (Moffat et al., 2006). Brieﬂy, syn-
thesized oligonucleotide pairs coding for the desired crRNA can
be annealed separately and ligated into the CRISPR vector. The
ligations can be transformed into competent bacteria in a 96-well
plate format. The resulting transformations from one plate can be
pooled andplated onto an agar plate for robotic colonypicking and
plasmid sequencing. This process showed a remarkable efﬁciency
when applied to the generation of genome-wide shRNA libraries
(Moffat et al., 2006).
It should be noted that other Cas family members and Cas
proteins from other organisms than Streptococcus pyogenes may
also be suitable for gene editing purposes. This can have signif-
icant advantages in the selection of the target sequence as some
Cas endonucleases have different requirements with regards to the
PAM motif, which currently restricts the target efﬁciency of Cas9
1www.addgene.org
2http://www.addgene.org/crispr/church/
3http://www.genome-engineering.org/crispr/?page_id=23
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FIGURE 1 | Design principle of a CRISPR/Cas9 expression vector for
construction of large-scale libraries.The vector requires two minimal
components, i.e., the single-guide RNA (sgRNA) sequence and the Cas9
gene that can both be expressed from a single-vector system. The sgRNA is
composed of a variable crRNA and a constant tracrRNA. The gene sequence
can be inserted by a simple adaptor cloning step in the 20 bp crRNA region.
Furthermore, multiple target sequences of the same gene can be inserted to
increase efﬁciency and reduce off-target effects. At the 3′-end of the crRNA
sequence, a 2 bp (base pair) protospacer adjacent motif (PAM – green box) of
the sequence GG is essential, but AG may be used to a lesser extend as well.
A 12 bp seed region (blue box) at the 3′-end is required for sequence tar-
geting with additional 8 bp at the 5′-end contributing to speciﬁcity (red box).
sgRNA expression can be driven by a U6 promoter or alternatively by a H1
promoter. The Cas9 component is currently available in three different forms:
as a wild-type (hCas9) or a mutant (D10A) version for gene editing purposes
and a catalytically dead (dCas9) version for gene silencing approaches. Exp-
ression of Cas9 can be driven by any mammalian expression promoter (e.g.,
EF1A, CMV, etc.) or retroviral promoter (LTR). For nuclear targeting, the Cas9
gene requires multiple nuclear localization signals (NLS) and general expre-
ssion of Cas9 can be enhanced by inclusion of a woodchuck post-transcrip-
tional regulatory element (WPRE) at the 3′-end. A polyA-tail is required for
expression vectors, while it should be deleted from lenti-/retroviral expression
vectors that have a polyA recognition sequence in their 3′-LTR. Variations of
this design are possible with respect to the Cas gene used or further modiﬁ-
cations such as tagging the Cas gene with GFP or NLSs in order to optimize
Cas9 nuclear targeting.
to GG-PAM. For a review on sequence requirements of Cas pro-
teins, please see Biswas et al., 2013.4 Furthermore, improvement
of Cas9 and sgRNA expression and assembly, sgRNA-5′ and 3′
modiﬁcations or nuclear targeting will readily allow for improved
CRISPR efﬁciency.
COVERAGE
The main restriction for the design of sgRNA sequences is the
PAMmotif. There is strong selection for a GGmotif, while the AG
motif might be used to a lesser extent as well (Jiang et al., 2013).
Accordingly, it was estimated that 1/8 of the genome hosts such
a motif, thus enabling very high coverage of genetic regions. The
Church lab has compiled a list of sites within the Saccharomyces
cerevisiae and H. sapiens genome with regions suitable for incor-
poration into the sgRNA (Dicarlo et al., 2013; Mali et al., 2013). It
was estimated that 40.5% exons of genes in the human genome
have a perfectmatch to the Streptococcus pyogenes Cas9 PAMmotif
and∼190,000 sgRNA-targetable sequences were identiﬁed in total
(Mali et al., 2013). Using other Cas9 family members that target
regions with different PAM motifs will enable a good coverage of
the whole-genome. It still needs to be established how to select the
best suitable sequence for each gene.
EFFICIENCY
The efﬁciency of gene silencing by various CRISPR/Cas9 systems
has been observed to be variable and dependent on the cell type, as
4http://bioanalysis.otago.ac.nz/CRISPRTarget
well as the guide RNA sequence. For instance, length and sequence
complementarity of the crRNA as well as the position to which the
crRNA binds within the gene locus, have been reported to affect
silencing efﬁciency (Gilbert et al., 2013; Qi et al., 2013). Repression
was inversely correlated with target distance to the transcription
start site. Mali et al. observed a targeting efﬁciency of 10–25% in
293T cells, 13–38% in K562 cells, and 2–4% in induced pluripo-
tent stem cells using wild-type Cas9 (Mali et al., 2013). Hwang
et al. (2013) achieved a targeting efﬁciency of >80% in zebraﬁsh.
TheCRISPRi systemusing catalytically inactive Cas9 achieved efﬁ-
ciencies of gene silencing of 46–63% in HEK293 cells and much
higher in E. coli (Qi et al., 2013).
Overall, the efﬁciency of knockdown needs further improve-
ment to about 70–80% in order to produce robust phenotypes.
With improvements in transfection or lenti-/retroviral infection
and expression protocols as well as sgRNA design principles, the
outlook is quite promising that this will be possible. Further, the
incorporation of a combination of multiple crRNA sequences into
each construct might be a possibility to enhance the efﬁciency of
knockdown.
OFF-TARGET EFFECTS
The effect of off-target silencing has been evaluated in only a few
examples. The minimal length of the base-pairing region within
the crRNA is 12 bp (“seed region”), which can in some cases lead to
signiﬁcant binding to other regions of the genome. A recent study
suggests that CRISPR-based genome editing has more off-target
effects than other genome editing tools such as TALENs or ZFNs
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(Fu et al., 2013). In another study, 3-bp mismatches did not
result in any detectable off-target effect for genome editing of
the CCR5 locus (Cho et al., 2013). A more systematic study
showed that single base and to a lesser extend two base mis-
matches are tolerated by SpCas9, thus potentially contributing
to off-target effects (Hsu et al., 2013). The group presented algo-
rithms to predict such off-target effects and therefore will enable
the selection of target sequences with minimal off-target effects5.
Another study that addressed the off-target effects of CRISPRi-
mediated silencing using RNA-seq has shown that silencing is
highly speciﬁcwithminimal off-target effects (Gilbert et al., 2013).
Further, combining two crRNAs drastically enhances silencing
efﬁciency (Qi et al., 2013) and may reduce off-target effects sig-
niﬁcantly. It is conceivable that the use of different systems (wt
vs. nickase vs. CRISPRi) and model organisms may result in
different off-target behavior. Some studies to date suggest that
CRISPR-mediated genome editing shows more off-target effects
than other genome editing tools, but has similar or better tar-
get gene speciﬁcity than RNAi-based silencing. Clearly, more
work needs to be done to evaluate the extent of off-target effects
carefully.
DELIVERY
The combination of both Cas9 endonuclease and the sgRNA in
one plasmid construct enables the use of single plasmid transfec-
tion into most standard cell lines. For primary cells, specialized
protocols for delivery such as those based on electroporation or
microinjection may have to be used (Marine et al., 2012; Hwang
et al., 2013). Transfection-based methods can be easily automated,
which enables the use of the CRISPR/Cas9 system for high-
throughput screening purposes. An alternative is the use of retro-
or lenti-viral transduction, although one should keep in mind
5See prediction tool at www.genome-engineering.org
that there are biosafety considerations and extra care must be
taken when handling humanized Cas9 endonuclease expression
constructs. The use of short-term selection such as puromycin
treatment can be included to enhance selection for stronger phe-
notypes (Wang et al., 2013). Longer selection and differentiation
protocols can even enable the generation of whole organism-based
silencing effects, for instance in zebraﬁsh or mice (Hwang et al.,
2013; Wang et al., 2013).
CONCLUSION
In conclusion, the design of a whole-genome targeted sgRNA
library is feasible provided that CRISPR/Cas components are fur-
ther optimized to ensure high-conﬁdence genome engineering.
Clearly, more data will be generated in the coming months to
evaluate carefully off-target effects and sequence requirements for
efﬁcient gene knockdown. Also, the assessment of other Cas9
proteins for genome editing and silencing will be an important
step forward. It should be noted that gene knockout of essential
genes may result in lethality effects, thus making the analysis of
more subtle phenotypes difﬁcult. In those cases, silencing strate-
gies such as RNAi-mediated knockdown or CRISPRi-mediated
gene repression may be beneﬁcial. Overall, given the simplic-
ity of use developments need to be encouraged for the design
of CRISPR/Cas-based large-scale whole-genome loss-of-function
screening applications. Current RNAi libraries are limited to three
model organisms, i.e., human, rat, and mouse. Since CRISPR
gene silencing works very well in multiple model organisms, the
development of libraries for other model organisms should be
particularly encouraged.
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